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sample consisted of 15 cases of the tongue and 15 of the lower lip. The pattern and intensity of the
labeling and the analysis of the percentage of tumor cells immunopositive in membrane for
E-cadherin and β-catenin were related to the anatomic location of the lesion, the presence or absence
of nodal metastasis, and the histological gradation of malignancy in the tumor invasion front. The
presence or absence of cytoplasmic and nuclear labeling was also recorded. The membrane
expression for E-cadherin and β-catenin predominately displayed a heterogeneous pattern in the
carcinomas studied. No significant difference was observed between the expression pattern and
the quantity of cells immunopositive for E-cadherin and β-catenin and the anatomic location of the
lesion or the presence or absence of nodal metastasis. However, a statistically significant difference
was found between the reduced expressio\n of these proteins and the high malignancy score. The
reduced immunoexpression of these proteins in the membrane may be related to the high degree of
cell indifferentiation in cases of oral squamous cell carcinoma with high scores.
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Cancer represents a global public health problem, which
is currently the third cause of death resulting from disease
[1]. Among the malignant neoplasias that affect the oral
cavity, squamous cell carcinoma is the most frequently
reported, accounting for more than 90% of cases [2]. In spite
of new and advanced therapeutic strategies, oral squamous
cell carcinoma (OSCC) shows poor survival rates [3].
The anatomical areas most affected by OSCC are the
tongue and lower lip [2], with tongue tumors showing a highuthor. Av. Senador Salgado Filho, 1787, Lagoa Nova,
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path.2008.07.006propensity for regional metastasis, poor prognosis, and
worse survival rates, whereas lower lip neoplasias show
better biological behavior than tumors in other anatomical
areas [4,5].
In OSCC, the presence or absence of cervical lymph node
involvement and distant metastases are important in patient
prognosis. It therefore becomes relevant for the pathologist
to search for characteristics in the histopathological analysis
to determine the stage of neoplasias invasion. The histolo-
gical characteristics of this carcinoma may differ from one
area to another within the same tumor owing to its
heterogeneous nature. Consequently, data collected in the
tumor invasion front may be more significant [6,7].
Molecular events important to tumor growth, such as the
loss and gain of adhesion molecules, occur in tumor-host
interaction, that is, in the front of the invasion front [7,8].
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the calcium present in most epithelial cells that play an
important role in intercellular adhesion and maintenance,
cellular polarity, and tissue architecture. It is composed of an
extracellular, transmembrane, and intercellular domain,
which links to the catenins and which is involved in signal
transduction mediated by these catenins. The cytoplasmic
domain of E-cadherin is directly linked to β-catenin or
γ-catenin, whereas the α-catenin connects the E-cadherin–
β-catenin and γ-catenin to the actin cytoskeleton. Recent
studies show that β- and γ-catenin act in cell adhesion and in
the Wnt signaling pathway, with the stability of both proteins
regulated by adenomatous polyposis coli [9].
Consequently, immunohistochemical studies using anti–
E-cadherin and anti–β-catenin antibodies, molecules that
participate in the cell-cell adhesion process in epithelial
tissues, have been performed to understand the significance
of the expression of these proteins in human cancers [10-12].
Alterations in E-cadherin and catenin expression are
associated with the loss of differentiation, acquisition of an
invasive phenotype, and poor clinical course of many types
of cancer. The role of these proteins in invasion and
neoplastic metastasis has attracted great interest owing to its
promise as a possible prognostic marker. This article aimed
to analyze the immunohistochemical expression of E-cad-
herin and β-catenin in squamous cell carcinoma of the lower
lip and tongue, correlating this expression to the anatomic
location of the lesion, the history of nodal metastasis, and the
histological gradation of malignancy proposed by Bryne in
1998 [7] to obtain a better understanding of the biological
behavior of this lesion.
2. Materials and methods
The sample is composed of 30 diagnosed cases of OSCC,
15 cases of the lower lip and 15 cases of the tongue, from the
files of the Instituto Maranhense de Oncologia Aldenora
Bello, São Luís/MA. Cases resulting from surgical treatment,
without prior chemotherapy or radiotherapy, were included
in the sample, whereas those whose paraffin-embedded
material was insufficient were excluded.Table 1
Expression pattern and amount of cells immunopositive for E-cadherin and β-cate
Location n Median Q25-Q75
Expression pattern
E-cadherin Lower lip 15 2 1-3
Tongue 15 2 1-3
β-catenin Lower lip 15 2 2-3
Tongue 15 2 2-3
Immunopositive cells
E-cadherin Lower lip 15 2 1-3
Tongue 15 1 1-3
β-catenin Lower lip 15 2 1-4
Tongue 15 2 1-3
a Mann-Whitney test.The clinical data collected were age and sex of the
patients and the presence or absence of nodal metastasis at
diagnosis. Histological cuts 5 μm thick were obtained from
the paraffin-embedded material and stained using the
hematoxilin/eosin technique to evaluate the areas of
deepest tumor invasion based on the malignancy criteria
recommended [7]. Specimens with a score of 4 to 8 points
were classified as having a low degree of malignancy,
whereas those with more than 8 points were considered to
have a high degree of malignancy, as proposed by Miranda
(2002) [13], which is an adaptation of Bryne's classifica-
tion (1998) [7].
Histological cuts 3 μm thick were obtained and
submitted to the immunohistochemical method, using the
streptoavidin-biotin technique. Following antigenic recov-
ery, using the citric acid (pH 6.0) steamer method, the
primary anti–E-cadherin (clone NCH-38, 1:50, DakoCyto-
mation, Carpinteria, CA) and anti–β-catenin antibodies
were incubated (clone Ab-1, 1:500, Labvision/Neomarkers,
Fremont, CA).
The pattern and intensity of the marking in the
cytoplasmic membrane for E-cadherin and β-catenin were
classified into 4 scores: 1 = absent, 2 = focal hetero-
geneous, 3= reduced homogeneous, and 4 = strong
homogeneous. The semiquantitative analysis of the
percentage of tumor cells positive for E-cadherin and β-
catenin with membrane expression was classified into
4 scores: 1 = less than 25%, 2 = 26% to 50%, 3 = 51% to
75%, and 4 = greater than 75% of positive cells [14]. For
the analysis of β-catenin, the presence of cytoplasmatic
and nuclear marking in the tumor cells at the invasion
front was also analyzed [15].
As a negative control, the primary antibody was
substituted for 1% bovine serum albumin in a buffer
solution, and the cuts were subsequently submitted to all
the steps described in the technique. As a positive control,
normal oral epithelium present in the areas circumjacent to
the lesions was used [14].
The Mann-Whitney test, Spearman coefficient correla-
tion, and Fisher exact test were used for the statistical
analysis, considering a significance level of 5%. This studynin in relation to lesion location
Mean of ranks Sum of ranks U Pa
15.27 229.00 109.00 .879
15.73 236.00
16.17 242.50 102.50 .650
14.83 222.50
15.53 233.00 112.00 .982
15.47 232.00
16.03 240.50 104.50 .730
14.97 224.50
Fig. 1. Immunohistochemical expression of E-cadherin in OSCC.
Cytoplasmic membrane expression with less than 25% of immunopositive
cells (arrow) (streptavidin-biotin, original magnification ×400).
ig. 3. Immunoreactivity in cytoplasmic membrane for E-cadherin in greater
an 75% of tumoral cells (arrows) (streptavidin-biotin, original magnifica-
on ×100).
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the University Hospital of the Universidade Federal
do Maranhão.3. Results
At diagnosis, the age of the patients varied between 34
and 91 years (mean age, 64.2 years). There were more men
than women. Nodal metastasis occurred in 11 (73.33%) of
the 15 cases of tongue carcinoma and in 3 (20%) of the 15
lower lip cases, a statistically significant association (P =
.009), with the tongue more often affected.
Following the morphological analysis, we observed that
11 (73.33%) of the 15 (73.33%) cases of squamous cell
carcinoma of tongue and 9 (60%) of the 15 lower lip cases
were among the group of high-score malignancy, with noFig. 2. Immunopositivity for E-cadherin in 26% to 50% of cells (arrow)
(streptavidin-biotin, original magnification ×400).F
th
tistatistically significant association found between lesion
location and malignancy scores (P = .700).
The presence of nodal metastasis was observed at
diagnosis in 14 cases of OSCC and absence in the remaining
16 cases. However, there was also no statistically significant
association (P = .709) found between nodal metastasis and
histological gradation of malignancy.
The cytoplasmic membrane expression for E-cadherin
was predominant, with a heterogeneous pattern (score 2) for
both lower lip and tongue carcinomas, as well as membrane
expression for β-catenin (Table 1) (Figs. 1-6). No significant
difference was found between the means for expression
pattern and the amount of immunopositive cells in the
antibodies analyzed.
In relation to nodal metastasis, no significant difference
was found between the means of expression pattern and the
amount of immunopositive cells for either E-cadherin orig. 4. Staining of β-catenin in OSCC. Reduced homogeneous pattern
treptavidin-biotin, original magnification ×400).F
(s
Fig. 5. Immunoreactivity for β-catenin with a focal heterogeneous pattern
(arrow) (streptavidin-biotin, original magnification ×100).
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observed in the membrane expression of the E-cadherin and
β-catenin proteins in relation to malignancy scores. Cases
with a low-malignancy score had significantly higher means
in both the expression pattern and amount of cells
immunopositive for E-cadherin β-catenin (Table 3).
There was no significant association between the nuclear
expression of β-catenin with the anatomic location of the
lesion, nodal metastasis, and histological gradation of
malignancy. There was also no significant association
between β-catenin expression in cytoplasm and the location
of the lesion and nodal metastasis. A significant association
was found between β-catenin expression in the cytoplasm
and histological gradation of malignancy, with β-catenin
present in the cytoplasm more often in cases of high
malignancy scores (Table 4).ig. 6. Cytoplasmic membrane immunoexpression for β-catenin with a
rong homogeneous pattern (streptavidin-biotin, original magnification
400).4. Discussion
Among the squamous cell carcinomas that occur in the
oral cavity, those of the tongue are the neoplasias that most
frequently develop nodal metastasis in initial tumors and are
associated with poor prognosis and low survival rates [3]. In
this study, we observed a high frequency of nodal metastasis
in the tongue cases (more than 70% of the sample), which is
in agreement with previous studies [16]; however, less
alarming values were presented [10], who detected the
presence in 41.18% of his sample.
In the lower lip, the presence of nodal metastasis was
significantly less frequent than in the tongue, corroborating
others studies, which found 79% of patients with squamous
cell carcinoma of lip without nodal metastasis [4], and
reported that lip neoplasias have better biological behavior
than that of tumors in other anatomical sites, possibly due to
the low rate of nodal metastasis and early detection because
of their location [5].The vascular and lymphatic systems vary between distinct
anatomical sites, a fact that may influence tumor develop-
ment [17]. The lower lymphatic vascularization in the lower
lip area appears to contribute to the low nodal metastasis rate
in cases of squamous cell carcinomas in this region at
diagnosis, as observed in this study. However, despite the
lower lip carcinoma's being negative at diagnosis, it may
develop nodal metastasis at a later stage, in most cases within
a 2-year period [18].
In the morphological analysis of the sample in this study,
we observed a predominance of lesions classified as high-
score malignancy, both for cases of the tongue (73.33%) and
of the lower lip (60%), with no statistically significant
association found between anatomical location and malig-
nancy scores.
In relation to the tongue lesions, our results were similar
to others reported by the literature [19], which observed a
predominance of squamous cell carcinomas of the tongue
with high malignancy scores. In other study [13], the
12 cases of tongue carcinoma (100%) had high malignancy
scores, whereas among the 12 cases of lower lip carcinoma,
only 8.33% were classified with a high score compared to
91.67% with a low malignancy score, differing from our
findings for the lower lip.
The distinct biological behavior of OSCC, when the
anatomical location of the primary tumor is analyzed, is
defended by some authors [4,5]. We found an association
between anatomical location and the formation of nodal
metastasis, which reflects the differences in biological
behavior between neoplasias and distinct anatomical regions
[2]. However, no association was found between either the
location of the tumor and the histological gradation of
malignancy, or location and nodal metastasis. This corrobo-
rates the previous findings of Okamoto et al [20] and
diverges from those of Odell et al [6], who found a relation





Expression pattern and amount of cells immunopositive for E-cadherin and β-catenin in relation to nodal metastasis
Nodal metastasis n Median Q25-Q75 Mean of ranks Sum of ranks U P
a
Expression pattern
E-cadherin Without metastasis 16 2 1.25-2.75 15.56 249.00 111.00 .965
With metastasis 14 2 1-3 15.43 216.00
β-catenin Without metastasis 16 2 2-3 15.28 244.50 108.50 .874
With metastasis 14 2 2-3.25 15.75 220.50
Immunopositive cells
E-cadherin Without metastasis 16 2 1-2.75 15.72 251.50 108.50 .875
With metastasis 14 1 1-3.25 15.25 213.50
β-catenin Without metastasis 16 2 1-4 15.91 254.50 105.50 .779
With metastasis 14 2 1-3.25 15.04 210.50
a Mann-Whitney test.
26 F.F. Lopes et al. / Annals of Diagnostic Pathology 13 (2009) 22–29E-cadherin links directly with the β-catenin protein, forming
the E-cadherin/β-catenin complex. β-Catenin may also act in
the Wnt signaling pathway. In the absence of Wnt signaling,
β-catenin has rapid phosphorylation and degradation;
however, with the activation of this signaling method, the
concentration of β-catenin in the cytoplasm rises, facilitating
its translocation to the nucleus. In the nucleus, the β-catenin
links with members of the TCF/LEF family of transition
factors and activates the expression of TCF/LEF target
genes, which include the protooncogenes c-Myc and cyclin
D1 [8,21].
The results of this study, in relation to the immunohis-
tochemical expression of E-cadherin and β-catenin mole-
cules, proved what was described previously [22,23]. These
studies revealed that cells positive for E-cadherin and β-ca-
tenin had a cuboidal format, whereas the negative cells were
fusiforms with greater loss of differentiation. In our research,
the tumor cells were predominantly negative when found in
small infiltrated or isolated islands, whereas the central cells
of the tumor masses were generally immunopositive, albeit
with a variable immunomarking pattern [24].
Also correlated in this study was the expression of E-
cadherin and β-catenin with the anatomic location of the
lesion, the presence of nodal metastasis and the histological
gradation of malignancy proposed by Bryne [7]. The results
showed that the heterogeneous focal pattern for E-cadherin
was predominant in both the lower lip and the tongue. These
results corroborate those of previous study [25], whoTable 3
Expression pattern and amount of cells immunopositive for E-cadherin and β-cate
Score of malignancy n Median Q25-Q
Expression pattern
E-cadherin Low 10 3 2-3
High 20 2 1-2
β-catenin Low 10 3 2-4
High 20 2 2-2
Immunopositive cells
E-cadherin Low 10 3 2-4
High 20 1 1-2
β-catenin Low 10 4 2.75-4
High 20 2 1-2
a Mann-Whitney test.reported that in malignant tumors, the E-cadherin immu-
noexpression is heterogeneous, with quantitative and
qualitative marking alterations. They also observed that in
normal oral mucous adjacent to the tumors, the E-cadherin
molecule displayed a strong pericellular immunopositivity in
the basal, suprabasal, and spinosum layers, with varying
intensity, confirming others' findings [5], who analyzed
85 epidermoid carcinomas of the tongue.
There was no significant difference in the pattern of
immunoexpression and amount of immunopositive cells for
the antibodies analyzed in this study, between the anatomical
locations of lesions in the lower lip and tongue. This result
corroborates with that of Bowie et al [26], who found no
association between E-cadherin expression and the anato-
mical location of tumors in 28 cases of squamous cell
carcinoma of the head and neck. There is, however, a scarcity
of studies comparing the variables of E-cadherin and β-ca-
tenin expression with tumor location. Most studies of these
proteins are correlated to histological gradation and the
appearance of metastasis.
There was also no significant difference between
expression pattern and the amount of immunopositive cells
for either E-cadherin or β-catenin and the nodal metastasis
variable. Studies with uterine carcinoma also found no
relation between the E-cadherin and β-catenin expression
and clinical-pathological data, such as recurrence, metasta-
sis, and survival [27]. They were also similar to the results
of Chow et al [10], who found no correlation betweennin in relation to the histological gradation of malignancy
75 Mean of ranks Sum of ranks U P
a
.25 21.50 215.00 40.00 .005
12.50 250.00
21.05 210.50 44.50 .008
12.73 254.50
21.80 218.00 37.00 .003
12.35 247.00
22.80 228.00 27.00 .001
11.85 237.00
Table 4




Negative n (%) Positive n (%) Pa Negative n (%) Positive n (%) Pa
Location Lower lip 05 (33.3) 10 (66.7) .682 14 (93.3) 01 (6.7) .169
Tongue 03 (20.0) 12 (80.0) 10 (66.7) 05 (33.3)
Nodal metastasis Without metastasis 05 (31.3) 11 (68.7) .689 14 (87.5) 02 (12.5) .378
With metastasis 03 (21.4) 11 (78.6) 10 (71.4) 04 (28.6)
Score of malignancy Low 06 (60.0) 04 (40.0) .007 09 (90.0) 01 (10.0) .633
High 02 (10.0) 18 (90.0) 15 (75.0) 05 (25.0)
a Fisher exact test.
27F.F. Lopes et al. / Annals of Diagnostic Pathology 13 (2009) 22–29E-cadherin and β-catenin expression and nodal metastasis in
85 squamous cell carcinomas of the tongue.
Diverging from our results, studies on oral carcinomas
[12] and on tongue carcinomas [19] showed significant
association between E-cadherin expression and lymph node
metastasis, considering the low expression of this protein as
an indicative value for cervical metastasis. However, Takes
et al [11], despite finding a significant correlation between
the presence of nodal metastasis and low E-cadherin
expression in OSCC, did not observe this relationship in
cases located in the pharynx.
In relation to β-catenin expression in the membrane, the
results of our study confirm those of Kurtz et al [28], who
found no significant association between β-catenin expres-
sion in the membrane and nodal metastasis in head and neck
carcinomas. However, our results diverge those reported by
others studies [9,12], which found that low β-catenin
expression was significantly related to nodal metastasis in
OSCCs and, according to the latter, also related to poor
patient prognosis.
This may be justified by the fact that the process of
tumor development and metastasis is complex, and it is
unlikely that a single molecular parameter could predict the
behavior of metastatic tumor cells [11]. The existence of
other factors involved in the formation of nodal metastasis
is still unclear [28].
The complexity of molecular mechanisms involved in the
formation of nodal metastasis was shown previously in a
study about head and neck squamous cell carcinomas [28],
which found no correlation between the presence of nodal
metastasis and low E-cadherin expression despite their
finding a significant association of the latter variable with
vascular invasion and lower survival of patients. Perhaps the
loss of cellular adhesion is merely an initial event in tumor
invasion, with other molecules necessary, such as matrix
metalloproteinases and integrins that function in extracel-
lular cell-matrix interaction, to consolidate the invasion and
promote the formation of nodal metastasis.
In this study, a statistically significant difference was found
in membrane expression of the E-cadherin and β-catenin
proteins in relation to malignancy scores. A moderately
negative correlation can be observed between the expressionpattern, the amount of immunopositive cells for E-cadherin
and β-catenin, and the total malignancy score. These results
are similar to some studies [19,23,24] that who showed that
E-cadherin expression was inversely proportional to the level
of tumor differentiation; however, they differ from the studies
[10,26] that did not find this correlation.
The significant correlation between the reduced β-catenin
expression in the membrane and the high malignancy score
observed in this study differ from those of Castro et al [29],
who found no such relation in esophageal carcinomas.
However, our results and those of Bànkfalvi et al [8] support
the theory that E-cadherin and β-catenin are involved in
tissue polarity and architecture and are significantly related to
histological gradation of the tumor invasion front in OSCC.
The immunohistochemical expression of β-catenin, not
only in the membrane but also in the cytoplasm and the
nucleus, showed that this expression in the cytoplasm was
more frequent than in the nucleus because, among 30 cases
of OSCC in this study, 22 (73.33%) showed cytoplasmatic
expression and 6 (20%) showed expression in the nucleus,
confirming that nuclear β-catenin appears not to be a
common finding in OSCC [30].
With regard to β-catenin expression in the cytoplasm, our
results were similar to those of Lo Muzio et al [22], who
found this marking in 18 of 30 cases of OSCC. In this study,
a significant association was observed between the cyto-
plasmic marking for β-catenin and the histological gradation
of malignancy, with the latter being more frequent in case of
high malignancy scores.
On the contrary, a study with ovarian carcinomas [21]
found no association between β-catenin expression in the
membrane and in cytoplasm with histological gradation of
malignancy. This difference in results may be explained by
the type of tumor, diversity of histological subtypes of
ovarian carcinomas, and differences in data analysis.
It is worth emphasizing that Lyakhovitsky et al [14]
observed the presence of β-catenin in the cytoplasm only in
cutaneous squamous cell carcinomas and not in precursor
lesions, suggesting that cytoplasmic β-catenin may reflect
the invasive potential of cells. The location of β-catenin is
considered important because the higher frequency of
cytoplasmic β-catenin was, the predetermining factor in the
28 F.F. Lopes et al. / Annals of Diagnostic Pathology 13 (2009) 22–29transference of this molecule to the nucleus of colorectal
carcinomas [15].
In this study, we found 6 (20%) cases with β-catenin
expression in the nucleus, and no association was found
between lesion location, nodal metastasis, and histological
gradation. In a sample of 24 OSCCs, only 2 (8.33%) cases
revealed nuclear expression located only in invasive cells
[31], whereas no nuclear marking was observed in 18 cases
of metastatic OSCCs [30].
The 20% frequency in our study of cases with of β-catenin
nuclear expression is similar to that detected by Pukkila et al
[32], who confirmed this expression in 23% (27 cases) of the
138 cases of squamous cell carcinoma of the pharynx. They
observed a correlation between β-catenin nuclear expression
and patient survival, whereas in our study, no such
correlation was found. In addition, patients with squamous
cell carcinoma of the esophagus that showed β-catenin
nuclear expression had lower mean survival in months than
those who did not show this expression [29], confirming the
need for further studies on β-catenin in carcinomas.
The clinical significance of β-catenin expression in the
cytoplasm and/or nucleus is controversial, where the intense
nuclear superexpression of this protein has been considered a
significant prognostic parameter for the low survival rate in
colorectal carcinoma. On the contrary, at other times, the
discovery of this high nuclear expression has been shown to
be a significant independent marker for a more favorable
prognosis in non–small cell lung carcinomas [9].
When studying β-catenin, we found that its cytoplasmatic
and nuclear immunoexpression findings are omitted in
various studies cited in the literature. More research on the
immunohistochemical expression of E-cadherin and β-
catenin is needed. Studies should investigate the presence
or absence of nodal metastasis in addition to patient survival
times to reach more significant conclusions.
Finally, we found that alterations in the immunohisto-
chemical expression of E-cadherin and β-catenin in the
membrane and the presence of β-catenin in the cytoplasm
and nucleus of OSCC cells observed in this study suggest
that these proteins may be involved in the aggressive
biological behavior of this neoplasia in invasive tumor
areas, with a greater loss of differentiation where this
association is evident.
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